The dysmorphogenic potential of phenytoin: experimental observations.
D000014:Abnormalities, Drug-Induced / Q000473:pathology*; D000818:Animals; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D005333:Fetus / Q000473:pathology; D005492:Folic Acid / Q000494:pharmacology; D005494:Folic Acid Deficiency / Q000150:complications; D000882:Haplorhini; D006801:Humans; D051379:Mice; D010672:Phenytoin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D051381:Rats; D013723:Teratogens / Q000494:pharmacology*
D013723:Teratogens; D010672:Phenytoin; D005492:Folic Acid